4//SEC Filing
Linde Peter 4
Accession 0001209191-21-056733
CIK 0001679363other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 7:04 PM ET
Size
13.5 KB
Accession
0001209191-21-056733
Insider Transaction Report
Form 4
Linde Peter
Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit (RSU
2021-09-16−10,378→ 0 totalExp: 2021-09-16→ Common Stock (10,378 underlying) - Exercise/Conversion
Common Stock
2021-09-16+10,378→ 15,272 total - Sale
Common Stock
2021-09-16$66.48/sh−3,276$217,803→ 11,896 total - Sale
Common Stock
2021-09-16$67.00/sh−624$41,805→ 11,272 total - Sale
Common Stock
2021-09-16$64.29/sh−100$6,429→ 15,172 total
Footnotes (6)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F2]Includes 294 shares of Common Stock acquired under the issuer's employee stock purchase plan on August 31, 2021.
- [F3]Represents the aggregate number of shares sold by the reporting person to cover taxes and fees due upon the release and settlement of the RSUs. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.89 to $66.8825 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.915 to $67.105 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]The RSU vests 50% on March 16, 2021 and the remaining 50% vests on September 16, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
Morphic Holding, Inc.
CIK 0001679363
Entity typeother
Related Parties
1- filerCIK 0001805908
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 7:04 PM ET
- Size
- 13.5 KB